ETH47

DRUG2 trials

Sponsors

Ethris GmbH

Conditions

Asthma (Diagnosis)Healthy Subjects

Phase 1

A Phase 1, First-in-human Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Ascending Doses of ETH47 in Healthy Participants

CompletedNCT07055321

Ethris GmbHHealthy Subjects

Start: 2023-11-29End: 2024-07-08Updated: 2025-07-08

Phase 2

Phase IIa Trial in Participants With Asthma to Evaluate Impact of Intranasal ETH47 on Development of Asthma-related Symptoms Following Rhinovirus Challenge

RecruitingNCT07059767

Ethris GmbHAsthma (Diagnosis)

Start: 2025-06-24End: 2026-06-01Target: 50Updated: 2026-06-26